Since our data suggested that CTCs display heterogenic gene expression profiles, especially with regard to EpCAM and to some cell surface proteins, we isolated CTCs using a parallel multi-orifice flow fractionation (p-MOFF) chip, which allows continuous isolation of EpCAM-positive and EpCAM-negative CTCs from the whole blood of breast cancer patients. The gene discussed is EPCAM; the disease is breast cancer.